⌘K

Home/Filings/4/0000950170-25-037514

4//SEC Filing

Barry Richard 4

Accession 0000950170-25-037514

CIK 0000873303other

View on SEC.gov Company Profile

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 8:00 PM ET

Size

8.3 KB

Accession

0000950170-25-037514

Insider Transaction Report

Form 4

Period: 2025-03-10

Sarepta Therapeutics, Inc.SRPT

Director

Transactions

Award
Common Stock
2025-03-10+2,383→ 2,934,071 total
Award
Stock Options (right to buy)
2025-03-10+4,792→ 4,792 total
Exercise: $99.69From: 2026-03-10Exp: 2035-03-10→ Common Stock (4,792 underlying)

Holdings

Common Stock
(indirect: By LLC)
10,000
Common Stock
(indirect: By Trust)
240,000

Footnotes (1)

[F1]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 10, 2026.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Sarepta Therapeutics, Inc.

CIK 0000873303

Entity typeother

Related Parties

1

filerCIK 0001562371

Filing Metadata

Form type: 4
Filed: Mar 10, 8:00 PM ET
Accepted: Mar 11, 8:00 PM ET
Size: 8.3 KB

View on SEC.gov